Abstract
Sphingosine is a potent inhibitor of a mammalian DNA primase in vitro (Simbulan et al., Biochemistry 33, 9007-9012, 1994). Here we measured the inhibition of DNA primase in vitro by 9 sphingosine-analogues with respect to RNA primer synthesis and DNA primase-dependent DNA synthesis, and their potencies of inhibition in vitro were compared with their in vivo effects on human leukemic cells. Sphingosine, phytosphingosine and N, N-dimethylsphingosine strongly inhibited the activity of purified calf thymus DNA primase, and also inhibited the growth of human leukemic cell line HL-60, exerting strong cytotoxicity. Dihydrosphingosine and cis-sphingosine, which showed more subtle inhibition of DNA primase in vitro, moderately inhibited the cell growth in vivo and caused cell death. In contrast, N-acyl-, N-octyl-, and N-acetylsphingosine (ceramides) showing little inhibition of DNA primase suppressed cell growth only slightly. HL 60 cell was arrested at Go/G1 phase by exogenously added sphingosine. From these results, it is suggested that DNA primase is one of targets of sphingosine, an effector molecule in apoptosis.
Citations
Nov 22, 2001·Biochemical and Biophysical Research Communications·M Takemura, S Yoshida
Jan 25, 2008·Lipids·Chisato IshimaruYoshiyuki Mizushina
Jul 30, 2010·Lipids·Sho HorieYoshiyuki Mizushina
Apr 23, 2003·Biochemical and Biophysical Research Communications·Yoshiyuki MizushinaKengo Sakaguchi
Apr 17, 2002·Biochimica Et Biophysica Acta·Chikako MurakamiYoshiyuki Mizushina
May 15, 2002·Biochimica Et Biophysica Acta·Chikako MurakamiYoshiyuki Mizushina
Jul 29, 1999·Journal of Hepatology·K TsuganeS Yoshida
Oct 29, 2002·Bioelectrochemistry·A V Alessenko, E B Burlakova
May 22, 2003·Biochimica Et Biophysica Acta·Yoshiyuki MizushinaKengo Sakaguchi
Sep 13, 2012·PloS One·Peng GaoCharles D Smith
Feb 13, 2014·PloS One·Moe KawamuraYoshiyuki Mizushina
Jan 26, 2010·Marine Drugs·Yoshiyuki MizushinaHiromi Yoshida
Oct 26, 2010·Journal of Oleo Science·Sho HorieYoshiyuki Mizushina
Jan 8, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yoshiyuki MizushinaHirosato Takikawa
Jul 6, 2010·Biochemical Pharmacology·Yoshiyuki MizushinaJunxuan Lü
Apr 21, 2009·Cancer Letters·Yuki MatsuiYoshiyuki Mizushina
May 20, 2015·Computational and Structural Biotechnology Journal·Julien BoudetGeorg Lipps
Dec 6, 2005·Biochemical and Biophysical Research Communications·Yoshiyuki MizushinaHiromi Yoshida
Apr 20, 2006·The Journal of Steroid Biochemistry and Molecular Biology·Yoshiyuki MizushinaHiromi Yoshida
Aug 6, 2005·The Journal of Nutritional Biochemistry·Isoko KuriyamaYoshiyuki Mizushina
Nov 6, 2003·Biochemical Pharmacology·Yoshiyuki MizushinaKengo Sakaguchi
Jun 21, 2005·Biochemical Pharmacology·Yuko YonezawaYoshiyuki Mizushina
Oct 21, 2005·Biochemical and Biophysical Research Communications·Yoshiyuki MizushinaHiromi Yoshida
Nov 23, 2006·Biochemical and Biophysical Research Communications·Naoki MaedaYoshiyuki Mizushina
May 3, 2002·Leukemia·P H O'DonnellB J Maurer
Jun 8, 2001·Annual Review of Biochemistry·D N Frick, C C Richardson
Dec 3, 1999·British Journal of Haematology·L YangY Ozaki
Mar 7, 2020·Journal of Biomolecular Structure & Dynamics·Deep BhowmikDiwakar Kumar
Jan 29, 2003·The Journal of Biological Chemistry·Stella Ibata-OmbettaThierry Jouault
Feb 18, 2004·World Journal of Gastroenterology : WJG·Zhi-Ming LiWen-Qi Jiang
Nov 7, 2019·Biochemistry. Biokhimii︠a︡·U A GutnerA V Alessenko
Jun 13, 2020·Frontiers in Neurology·Alice V Alessenko, Elisabetta Albi
Aug 15, 2018·Antibiotics·Stefan IlicBarak Akabayov
Sep 6, 2021·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A V AlessenkoA A Ustyugov